NEW YORK (TheStreet) --CHANGE IN RATINGS
Mattress Firm (MFRM) was initiated at Jefferies with a buy rating. Unit growth story with positive new store economics, Jefferies said. Twelve-month price target is $56.
Susser Petroleum (SUSS) was initiated at Jefferies with a hold rating. Valuation call, with positive foodservice story and 4%-5% store growth, Jefferies said. Twelve-month price target is $72.
Teva (TEVA) - Get Report was upgraded at Goldman Sachs to neutral from sell. Copaxone slowdown is largely priced in and the underlying business can deliver growth, Goldman Sachs said. Twelve-month price target is $52.
[Read: Apple Must Do a TV]
Stock Comments / EPS Changes
Adobe (ADBE) - Get Report estimates, price target were raised at JMP Securities. Shares are now seen reaching $78. Estimates were also increased, given the company's guidance, JMP Securities said. Outperform rating.
Dow Chemical (DOW) - Get Report estimates, price target were boosted at Citigroup. Twelve-month price target is now $57. Estimates were also increased, given higher expected ethylene margins, Citigroup said. Buy rating.
[Read: Millennials Actively Seek to Live Closer to Work]
Enterprise Products Partners (EPD) - Get Report 12-month price target was raised at UBS. Continued focus on diversification, stability and growth, UBS said. Twelve-month price target is $74. Buy rating.
Freescale (FSL) estimates, 12-month price target were increased at Drexel Hamilton. Estimates were boosted through 2015. Rising capacity utilization should help margins, Drexel Hamilton said. Buy rating and new $30 price target.
Johnson & Johnson (JNJ) - Get Report price target was lifted at Jefferies. Driven by regulatory catalysts and several major congresses, Jefferies said. Twelve-month price target is now $105. Buy rating.
Oracle (ORCL) - Get Report price target, EPS estimates were increased at Jefferies. Valuation call, with modestly higher revenue forecasts, Jefferies said. Twelve-month price target is now $37. Hold rating.
ING (VOYA) - Get Report estimates, price target were increased at Credit Suisse. Estimates were raised through 2015. Company is returning more capital to shareholders, Credit Suisse said. Neutral rating and new 12-month price target of $41.
This article was written by a staff member of TheStreet.